Breast Cancer Awareness Month has highlighted a pressing health crisis among Indian women, particularly those aged 55 to 64. A recent report by Healthians reveals that 16% of women in this demographic are affected by breast cancer. This alarming statistic underscores the urgent need for awareness,
The pharmaceutical industry is no stranger to challenges and setbacks, especially in the area of neurological and psychiatric treatments. AbbVie, a multinational biopharmaceutical company, recently faced a significant hurdle when its promising schizophrenia drug, emraclidine, failed to meet
The gene therapy sector, once a beacon of hope for revolutionary treatments, has seen a significant slowdown in investment post the COVID-19 pandemic. This downturn follows a period of unprecedented financial influx during the pandemic years, raising questions about the future of this promising
The election of Donald Trump and his return to the White House have sparked significant discussions about the potential impacts on various sectors, particularly the biopharma and vaccine industries. With anticipated shifts in federal policies and key personnel appointments, stakeholders are keenly
Urticaria, commonly known as hives, is a prevalent skin condition affecting up to 20% of the global population at some point in their lives, causing a significant impact on individuals' quality of life. It is characterized by the rapid appearance of raised, itchy welts or wheals on the skin
In October 2023, Sanofi, a leading global pharmaceutical company, announced a major shift in its business strategy. This shift involved the separation of its consumer health division, a move set to be completed in 2024. Historically, Sanofi's consumer health division, which includes popular
